JP2004502674A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502674A5
JP2004502674A5 JP2002507781A JP2002507781A JP2004502674A5 JP 2004502674 A5 JP2004502674 A5 JP 2004502674A5 JP 2002507781 A JP2002507781 A JP 2002507781A JP 2002507781 A JP2002507781 A JP 2002507781A JP 2004502674 A5 JP2004502674 A5 JP 2004502674A5
Authority
JP
Japan
Prior art keywords
methyl
isopropyl
pyridyl
pyrrole
dichlorophenylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002507781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502674A (ja
Filing date
Publication date
Priority claimed from GBGB0016453.3A external-priority patent/GB0016453D0/en
Application filed filed Critical
Publication of JP2004502674A publication Critical patent/JP2004502674A/ja
Publication of JP2004502674A5 publication Critical patent/JP2004502674A5/ja
Pending legal-status Critical Current

Links

JP2002507781A 2000-07-04 2001-04-30 エイズを治療するためのピロール誘導体 Pending JP2004502674A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016453.3A GB0016453D0 (en) 2000-07-04 2000-07-04 Pyrrole derivatives
PCT/EP2001/004832 WO2002002524A1 (en) 2000-07-04 2001-04-30 Pyrrole derivatives for treating aids

Publications (2)

Publication Number Publication Date
JP2004502674A JP2004502674A (ja) 2004-01-29
JP2004502674A5 true JP2004502674A5 (enExample) 2005-02-24

Family

ID=9895031

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002507781A Pending JP2004502674A (ja) 2000-07-04 2001-04-30 エイズを治療するためのピロール誘導体

Country Status (17)

Country Link
US (1) US6737429B2 (enExample)
EP (1) EP1301481A1 (enExample)
JP (1) JP2004502674A (enExample)
KR (1) KR100549884B1 (enExample)
CN (1) CN1440385A (enExample)
AR (1) AR028602A1 (enExample)
AU (2) AU2001263874B2 (enExample)
BR (1) BR0112241A (enExample)
CA (1) CA2412270A1 (enExample)
EC (1) ECSP014109A (enExample)
GB (1) GB0016453D0 (enExample)
GT (1) GT200100111A (enExample)
MX (1) MXPA02012409A (enExample)
PA (1) PA8516201A1 (enExample)
PE (1) PE20020269A1 (enExample)
UY (1) UY26720A1 (enExample)
WO (1) WO2002002524A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1405849A1 (en) * 2002-10-04 2004-04-07 Corning Incorporated Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom
DK2666481T3 (en) * 2003-12-26 2019-02-25 Masatoshi Hagiwara A method for regulating the phosphorylation of SR protein and antiviral agents comprising an SR protein activity regulator as the active ingredient
JP5173192B2 (ja) 2004-09-30 2013-03-27 武田薬品工業株式会社 プロトンポンプ阻害薬
TW200628446A (en) * 2004-12-14 2006-08-16 Takeda Pharmaceuticals Co Substituted pyrrole derivative
CA2592909A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
KR101115857B1 (ko) 2005-08-30 2012-04-12 다케다 야쿠힌 고교 가부시키가이샤 산 분비 억제제로서 1-헤테로시클릴술포닐, 2-아미노메틸,5-(헤테로-) 아릴 치환된 1-h-피롤 유도체
EP2076492A4 (en) * 2006-10-06 2010-12-22 Merck Sharp & Dohme NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS
US20080242648A1 (en) * 2006-11-10 2008-10-02 Syndax Pharmaceuticals, Inc., A California Corporation COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
WO2009015180A2 (en) * 2007-07-23 2009-01-29 Syndax Pharmaceuticals, Inc. Novel compounds and methods of using them
SG10201602750RA (en) * 2007-10-16 2016-05-30 Nikon Corp Illumination Optical System, Exposure Apparatus, And Device Manufacturing Method
WO2009067453A1 (en) * 2007-11-19 2009-05-28 Syndax Pharmaceuticals, Inc. Combinations of hdac inhibitors and proteasome inhibitors
NZ591793A (en) 2008-08-27 2012-11-30 Takeda Pharmaceutical Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds
GB0823001D0 (en) * 2008-12-17 2009-01-28 Syngenta Participations Ag Thiophene,furan and pyrrole derivatives with plant growth regulating properties
CN101775011B (zh) * 2009-01-13 2013-07-31 中国人民解放军军事医学科学院毒物药物研究所 N-取代苯基-3-甲烯杂环芳烃-2,5-二甲基吡咯类化合物及其抗hiv/aids的应用
WO2021102114A1 (en) * 2019-11-19 2021-05-27 New York Blood Center, Inc. Substituted heterocyclics with therapeutic activity in hiv

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644631A (en) * 1969-05-13 1972-02-22 Endo Lab Therapeutic methods utilizing aryl pyrrol-3-yl ketones
US4282242A (en) * 1980-03-07 1981-08-04 Pfizer Inc. Antidiabetic pyrrolecarboxylic acids
US4347186A (en) * 1980-10-20 1982-08-31 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein
KR100190730B1 (ko) * 1992-12-17 1999-06-01 디. 제이. 우드, 스피겔 알렌 제이 부신피질 호르몬 유리인자(crf) 길항물질로서 치환된 피라졸
EP0764153A1 (en) * 1994-06-06 1997-03-26 Pfizer Inc. Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
AU3044197A (en) * 1996-07-11 1998-02-09 Pfizer Inc. Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
DE19963174A1 (de) * 1999-12-27 2001-07-12 Gruenenthal Gmbh Substituierte Pyrrol-Mannichbasen

Similar Documents

Publication Publication Date Title
JP2021535104A5 (enExample)
RU2425838C2 (ru) Ингибиторы iap
JP2008502700A5 (enExample)
RU2312105C9 (ru) N-пиразинилфенилсульфонамиды и их применение при лечении опосредованных хемокинами заболеваний
RU97107997A (ru) Соединения дигалогенпропена, содержащие их инсектицидно/акарицидные агенты, и интермедиаты для их получения
JP2019518036A5 (enExample)
JP2005527625A5 (enExample)
JP2013516415A5 (enExample)
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
JP2010540462A5 (enExample)
JP2010533158A5 (enExample)
JP2021535134A5 (enExample)
JP2004517080A5 (enExample)
JP2010513304A5 (enExample)
JP2010529991A5 (enExample)
JP2007508346A5 (enExample)
RU2003112610A (ru) Производные пиразола для лечения вирксных заболеваний
JP2006500369A5 (enExample)
JP2007308471A5 (enExample)
JP2004511469A5 (enExample)
JP2011500679A5 (enExample)
JP2020532589A5 (enExample)
JP2020500192A5 (enExample)
JP2023062064A5 (enExample)
JP2009514866A5 (enExample)